Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 1320Neoplasms 1100Carcinoma, Non-Small-Cell Lung 911Prostatic Neoplasms 741Colorectal Neoplasms 648Lung Neoplasms 611Neoplasm Metastasis 469Multiple Myeloma 444Leukemia, Myeloid, Acute 428Pancreatic Neoplasms 388Ovarian Neoplasms 387Melanoma 342Carcinoma, Hepatocellular 308Recurrence 289Brain Neoplasms 286Squamous Cell Carcinoma of Head and Neck 284Glioblastoma 259Head and Neck Neoplasms 253Stomach Neoplasms 251Precursor Cell Lymphoblastic Leukemia-Lymphoma 240Carcinoma, Renal Cell 237Triple Negative Breast Neoplasms 233Lymphoma 232Endometrial Neoplasms 221Hematologic Neoplasms 214Uterine Cervical Neoplasms 212Urinary Bladder Neoplasms 210Lymphoma, Non-Hodgkin 205Glioma 202Sarcoma 201

Interventions

oprelvekin 1Interleukin-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
CTIT: Cancer Therapy Induced Thrombocytopenia × 90 days × Clear all
NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
88 enrolled
Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡